1. Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012.
- Author
-
Mahowald, Madeline K., Larney, Sarah, Zaller, Nickolas D., Scharff, Nicholas, Taylor, Lynn E., Beckwith, Curt G., Noska, Amanda, Rich, Josiah D., and Flanigan, Timothy P.
- Subjects
AUTHORSHIP ,CONFIDENCE intervals ,CORRECTIONAL institutions ,HEALTH ,HEPATITIS C ,POPULATION ,MEDICAL care of prisoners ,PUBLIC health ,SURVEYS ,CROSS-sectional method - Abstract
Although hepatitis C (HCV) infection is common among prisoners, relatively few undergo evaluation for treatment. This study reports the prevalence of chronic infection and the genotype distribution among an incarcerated population. HCV antibody testing was provided to adults entering Pennsylvania prisons; confirmatory and genotype testing were offered to those eligible for treatment. Antibody prevalence among 101,727 individuals was 18.1%. Among 7,633 individuals who underwent confirmatory testing, 69.3% had detectable RNA. Among 3,247 individuals who underwent genotype testing, genotype 1 was the most common (76.6%). The rate of chronic infection after HCV exposure is similar to that reported in the community, as is genotype distribution. Correctional facilities provide access to a population with a high disease burden, creating a public health opportunity for evaluation and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF